Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02943265 · ClinicalTrials.gov registry record · NA
Care Coordination for Complex Cancer Survivors in an Integrated Safety Net System
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 4,322
- Enrollment target
NCT02943265: Completed NA study, sponsored by University of Texas Southwestern Medical Center.
NCT02943265 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 4,322 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (208% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02943265, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,322 participants
- Enrollment target
Study Summary
Nearly 70% of people living with cancer are "complex patients" with multiple chronic conditions who must deal not only with effects of their cancer but also continuing diseases such as diabetes, depression, hypertension, or heart disease. Care coordination strategies shown to be effective in improving outcomes for common medical conditions seen in primary care include: systematic transitions for patients to and from specialty care; intensive case management; and a team-based approach to comprehensive care. Despite an Institute of Medicine report suggesting these strategies as potential ways to improve care for cancer survivors, their implementation has not yet been evaluated for cancer survivors. Parkland Health and Hospital Systems will be implementing care coordinator strategies as part of as quality assurance/quality improvement activities, which Aim 2 and Aim 3 (research components) will evaluate. This protocol has been organized to reflect this distinction between the aims. The investigators expect no more than 1500 patients to be included in these study aims.
Primary Outcome
Proportion of complex cancer survivors meeting quality of care guidelines for multiple chronic conditions and follow-up cancer surveillance
Interventions
- OTHER Care Coordination Strategies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,322 participants |
| Start Date | 2017-09-18 |
| Est. Completion | 2022-04-30 |
| Phase | NA |
What the finished NCT02943265 record still lists
NCT02943265 is an interventional study that assigns participants to a tested intervention. Its 4,322 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (208% higher).
The record links to 0 conditions, and to 1 intervention - of which Care Coordination Strategies is the first listed.
NCT02943265 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02943265 about?
NCT02943265 is a clinical study titled "Care Coordination for Complex Cancer Survivors in an Integrated Safety Net System". Nearly 70% of people living with cancer are "complex patients" with multiple chronic conditions who must deal not only with effects of their cancer but also continuing diseases such as diabetes, depression, hypertension, or heart disease. Care coordination strategies shown to be effective in improvi...
What is the current status of trial NCT02943265?
This trial is currently completed. It is a NA study. The enrollment target is 4,322 participants. The study started on 2017-09-18. Estimated completion is 2022-04-30.
What interventions are being tested in trial NCT02943265?
The interventions under investigation include: Care Coordination Strategies (OTHER).
Who is sponsoring clinical trial NCT02943265?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02943265's enrollment target sits among peer trials
4,322 30th of 2000 higher than 1,971 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05774951 · 4,300 participants · Phase 3
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
- NCT05910567 · 4,346 participants · NA
A Research Study of Abdominal Ultrasound (FAST) in Children With Blunt Torso Trauma
- NCT05543616 · 4,292 participants · Phase 2
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
- NCT07044297 · 4,390 participants · Phase 3
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI